URGENT PANDEMIC INFORMATION

In light of the pandemic situation all of our 2021 events are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


Ligase Targeting Drug Development Summit - May 2021 - Digital Event


Date
May 25, 2021 - 08:30 AM - May 27, 05:00 PM
Organizer
Hanson Wade
Venue
online
Location
Online,

Online,
Online,
US,
ZIP: 00000
Phone: +16174554188

Ticket Price: Conference Only: USD 1999.0, Conference + 1 Workshop: USD 2348.0, Conference + 2 Workshops: USD 2697.0


As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day.

Built with large pharma and biotech insight, the Ligase Targeting Drug Development Summit is fully dedicated to enabling novel ligase discovery and characterization, achieving cell and tissue specificity and expanding chemical biology tools to therapeutically leverage ubiquitin ligases for effective protein modulation or degradation strategies.

As leading pharma companies join forces to bridge the gap between the functional knowledge and true translational value of ubiquitin ligases and their associated ligands, join us to advance your understanding, differentiate your pipelines and tap into the uncapped therapeutic potentials of this emerging field.

Take advantage of our group discounts, academic rates and earlybird savings - don't miss out register now for the best rate!

URLs:
Tickets: https://go.evvnt.com/717315-2?pid=1052
Brochure: https://go.evvnt.com/717315-3?pid=1052


Speaker Details


Chris De Savi Vice President Head of Drug Discovery Kymera, Miklos Bekes Senior Research Investigator and Group Leader in Platform Biology Arvinas, Daniel Nomura Professor of Chemistry, University of California Berkeley, Alex Bullock Associate Professor, University of Oxford Centre for Medicines Discovery, Benedict Cross Chief Technology Officer PhoreMost Ltd, Claudio Thomas Senior Principal Scientist Novartis Institutes for Biomed Research, Inc, Ingo Hartung Director Medicinal Chemistry Merck, Joe Patel Senior Director C4 Therapeutics, Nicholas Brown Assistant Professor University of North Carolina, Rick Davies Associate Director AstraZeneca Pharmaceuticals, Ryan Potts Executive Director and Head of IPP Amgen, Kumar Suresh Senior Director R and D Progenra Inc, Roman Erdmann Senior Scientist Merck, Yue Xiong CSO Cullgen Inc, Nicolas Thomä Senior Group Leader Friedrich Miescher Institute for Biomedical Research in Basel, Radosław Nowak Scientist, Cancer Biology Dana-Farber Cancer Institute, Danny Huang Senior Group Leader and Professor of Cancer Structural Biology University of Glasgow, Matthew Calabrese Senior Director and Head of Structural and Molecular Sciences Pfizer, Feng Wang Lab Head of Protein Homeostasis and Principal Scientist Pfizer, Pengyu Yang Associate Director Plexium, Markus Queisser Scientific Leader GlaxoSmithKline, Nico Zinn Group Leader Mass Spectrometry Cellzome, Jeff McKenna Associate Director, Global Discovery Chemistry Novartis Institutes for BioMedical Research

Event Categories
Keywords: pharmaceutical , Medicine




Comments








Events Calendar

SunMonTueWedThuFriSat
25 26 27 28 29 30 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 1 2 3 4 5

Event Location

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99